Chronic rhinosinusitis: the rationale for current treatments

References

• Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol. 2011;120(7):423–427.
   PubMed Web of Science ®Google Scholar
• Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe – an underestimated disease. A GA(2)LEN study. Allergy. 2011;66(9):1216–1223.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;50(23):3 p preceding table of contents, 1–298.
   Google Scholar
• Kern RC, Conley DB, Walsh W, et al. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol. 2008;22(6):549–559.
   PubMedGoogle Scholar
• Lam K, Schleimer R, Kern RC. The etiology and pathogenesis of chronic rhinosinusitis: a review of current hypotheses. Curr Allergy Asthma Rep. 2015;15(7):41.
   PubMed Web of Science ®Google Scholar
• Tan BK, Li QZ, Suh L, et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2011;128(6):1198–1206.e1.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Bachert C, Cingi C, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131(6):1479–1490.
   PubMed Web of Science ®Google Scholar
• Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–1456.e4.
   PubMed Web of Science ®Google Scholar
• Feazel LM, Frank DN, Ramakrishnan VR. Update on bacterial detection methods in chronic rhinosinusitis: implications for clinicians and research scientists. Int Forum Allergy Rhinology. 2011;1(6):451–459.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan VR, Feazel LM, Gitomer SA, et al. The microbiome of the middle meatus in healthy adults. PLoS One. 2013;8(12):e85507.
   PubMed Web of Science ®Google Scholar
• Yan M, Pamp SJ, Fukuyama J, et al. Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe. 2013;14(6):631–640.
   PubMed Web of Science ®Google Scholar
• Seshadri S, Rosati M, Lin DC, et al. Regional differences in the expression of innate host defense molecules in sinonasal mucosa. J Allergy Clin Immunol. 2013;132(5):1227–1230.e5.
   PubMed Web of Science ®Google Scholar
• Abreu NA, Nagalingam NA, Song Y, et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med. 2012;4(151). 151ra124 - NOTE TO EDITOR - they have an unusual numbering system.
   PubMed Web of Science ®Google Scholar
• Feazel LM, Robertson CE, Ramakrishnan VR, et al. Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis. Laryngoscope. 2012;122(2):467–472.
   PubMed Web of Science ®Google Scholar
• Stephenson MF, Mfuna L, Dowd SE, et al. Molecular characterization of the polymicrobial flora in chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2010;39(2):182–187.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan VR, Hauser LJ, Feazel LM, et al. Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome. J Allergy Clin Immunol. 2015;136(2):334–342 e1.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan VR, Hauser LJ, Frank DN. The sinonasal bacterial microbiome in health and disease. Curr Opin Otolaryngol Head Neck Surg. 2016;24(1):20–25.
   PubMed Web of Science ®Google Scholar
• Liu CM, Kohanski MA, Mendiola M, et al. Impact of saline irrigation and topical corticosteroids on the postsurgical sinonasal microbiota. Int Forum Allergy Rhinol. 2015;5(3):185–190.
   PubMed Web of Science ®Google Scholar
• Liu CM, Soldanova K, Nordstrom L, et al. Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis. Int Forum Allergy Rhinol. 2013;3(10):775–781.
   PubMed Web of Science ®Google Scholar
• Von Mutius E. The microbial environment and its influence on asthma prevention in early life. J Allergy Clin Immunol. 2016;137(3):680–689.
   PubMed Web of Science ®Google Scholar
• Lynch SV, Boushey HA. The microbiome and development of allergic disease. Curr Opin Allergy Clin Immunol. 2016;16(2):165–171.
   PubMed Web of Science ®Google Scholar
• Fujimura KE, Lynch SV. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe. 2015;17(5):592–602.
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Martinez FJ, et al. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78:481–504.
   PubMed Web of Science ®Google Scholar
• Cleland EJ, Drilling A, Bassiouni A, et al. Probiotic manipulation of the chronic rhinosinusitis microbiome. Int Forum Allergy Rhinol. 2014;4(4):309–314.
   PubMed Web of Science ®Google Scholar
• Zheng J, Ganzle MG, Lin XB, et al. Diversity and dynamics of bacteriocins from human microbiome. Environ Microbiol. 2015;17(6):2133–2143.
   PubMed Web of Science ®Google Scholar
• Islam SU. Clinical uses of probiotics. Medicine (Baltimore). 2016;95(5):e2658.
   PubMed Web of Science ®Google Scholar
• Vliagoftis H, Kouranos VD, Betsi GI, et al. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol. 2008;101(6):570–579.
   PubMed Web of Science ®Google Scholar
• Cope EK, Lynch SV. Novel microbiome-based therapeutics for chronic rhinosinusitis. Curr Allergy Asthma Rep. 2015;15(3):504.
   PubMed Web of Science ®Google Scholar
• Hauser LJ, Ir D, Kingdom TT, et al. Investigation of bacterial repopulation after sinus surgery and perioperative antibiotics. Int Forum Allergy Rhinol. 2016;6(1):34–40.
   PubMed Web of Science ®Google Scholar
• Nadel DM, Lanza DC, Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol. 1998;12(4):233–241.
   PubMedGoogle Scholar
• Kingdom TT, Swain RE Jr. The microbiology and antimicrobial resistance patterns in chronic rhinosinusitis. Am J Otolaryngol. 2004;25(5):323–328.
   PubMed Web of Science ®Google Scholar
• Smith SS, Evans CT, Tan BK, et al. National burden of antibiotic use for adult rhinosinusitis. J Allergy Clin Immunol. 2013;132(5):1230–1232.
   PubMed Web of Science ®Google Scholar
• Orlandi RR, Kingdom TT, Hwang PH, et al. International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol. 2016;6 Suppl 1:S22–s209.
   PubMed Web of Science ®Google Scholar
• Tan BK, Kern RC, Schleimer RP, et al. Chronic rhinosinusitis: the unrecognized epidemic. Am J Respir Crit Care Med. 2013;188(11):1275–1277.
   PubMed Web of Science ®Google Scholar
• Soler ZM, Oyer SL, Kern RC, et al. Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations. Int Forum Allergy Rhinol. 2013;3(1):31–47.
   PubMed Web of Science ®Google Scholar
• Merkley MA, Bice TC, Grier A, et al. The effect of antibiotics on the microbiome in acute exacerbations of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5(10):884–893.
   PubMed Web of Science ®Google Scholar
• Walgama E, Thanasumpun T, Gander R, et al. Comparison of endoscopically-guided swab vs aspirate culture techniques in post-endoscopic sinus surgery patients: blinded, prospective analysis. Int Forum Allergy Rhinol. 2013;3(9):726–730.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya N, Kepnes LJ. The microbiology of recurrent rhinosinusitis after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg. 1999;125(10):1117–1120.
   PubMedGoogle Scholar
• Ikeda K, Yokoi H, Kusunoki T, et al. Bacteriology of recurrent exacerbation of postoperative course in chronic rhinosinusitis in relation to asthma. Auris Nasus Larynx. 2011;38(4):469–473.
   PubMed Web of Science ®Google Scholar
• Rank MA, Wollan P, Kita H, et al. Acute exacerbations of chronic rhinosinusitis occur in a distinct seasonal pattern. J Allergy Clin Immunol. 2010;126(1):168–169.
   PubMed Web of Science ®Google Scholar
• Adelson RT, Adappa ND. What is the proper role of oral antibiotics in the treatment of patients with chronic sinusitis? Curr Opin Otolaryngol Head Neck Surg. 2013;21(1):61–68.
   PubMed Web of Science ®Google Scholar
• Harvey RJ, Wallwork BD, Lund VJ. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis. Immunol Allergy Clin North Am. 2009;29(4):689–703.
   PubMed Web of Science ®Google Scholar
• Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006;116(2):189–193.
   PubMed Web of Science ®Google Scholar
• Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66(11):1457–1468.
   PubMed Web of Science ®Google Scholar
• Head K, Chong LY, Piromchai P, et al. Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:Cd011994.
   PubMedGoogle Scholar
• Li X, Wang M, Liu G, et al. Macrolides use and the risk of sudden cardiac death. Expert Rev Anti Infect Ther. 2016;14(6):535–537.
   PubMed Web of Science ®Google Scholar
• Cheng YJ, Nie XY, Chen XM, et al. The role of macrolide antibiotics in increasing cardiovascular risk. J Am Coll Cardiol. 2015;66(20):2173–2184.
   PubMed Web of Science ®Google Scholar
• Bewick J, Ahmed S, Carrie S, et al. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis. Clin Otolaryngol. 2016:8. doi:10.1111/coa.12685.
   Google Scholar
• Bachert C, Zhang N, van Zele T, et al. Staphylococcus aureus enterotoxins as immune stimulants in chronic rhinosinusitis. Clin Allergy Immunol. 2007;20:163–175.
   PubMedGoogle Scholar
• Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069–1076.e4.
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322.
   PubMed Web of Science ®Google Scholar
• Hoyle BD, Costerton JW. Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res. 1991;37:91–105.
   PubMedGoogle Scholar
• Bezerra TF, Padua FG, Gebrim EM, et al. Biofilms in chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg. 2011;144(4):612–616.
   PubMed Web of Science ®Google Scholar
• Suh JD, Cohen NA, Palmer JN. Biofilms in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2010;18(1):27–31.
   PubMed Web of Science ®Google Scholar
• Foreman A, Holtappels G, Psaltis AJ, et al. Adaptive immune responses in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Allergy. 2011;66(11):1449–1456.
   PubMed Web of Science ®Google Scholar
• Chiu AG, Palmer JN, Woodworth BA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol. 2008;22(1):34–37.
   PubMedGoogle Scholar
• Fokkens WJ, Ebbens F, Van Drunen CM. Fungus: a role in pathophysiology of chronic rhinosinusitis, disease modifier, a treatment target, or no role at all? Immunol Allergy Clin North Am. 2009;29(4):677–688.
   PubMed Web of Science ®Google Scholar
• Bassiouny A, Ragab A, Attia AF, et al. Prevalence of extramucosal fungal elements in sinonasal polyposis: a mycological and pathologic study in an Egyptian population. Am J Otolaryngol. 2011;32(4):308–317.
   PubMed Web of Science ®Google Scholar
• Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999;74(9):877–884.
   PubMed Web of Science ®Google Scholar
• Ponikau JU, Sherris DA, Kephart GM, et al. The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol. 2006;30(3):187–194.
   PubMed Web of Science ®Google Scholar
• Sacks PLt, Harvey RJ, Rimmer J, et al. Antifungal therapy in the treatment of chronic rhinosinusitis: a meta-analysis. Am J Rhinol Allergy. 2012;26(2):141–147.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, van Drunen C, Georgalas C, et al. Role of fungi in pathogenesis of chronic rhinosinusitis: the hypothesis rejected. Curr Opin Otolaryngol Head Neck Surg. 2012;20(1):19–23.
   PubMed Web of Science ®Google Scholar
• Pothoven KL, Norton JE, Hulse KE, et al. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. J Allergy Clin Immunol. 2015;136(3):737–746.e4.
   PubMed Web of Science ®Google Scholar
• Wise SK, Laury AM, Katz EH, et al. Interleukin-4 and interleukin-13 compromise the sinonasal epithelial barrier and perturb intercellular junction protein expression. Int Forum Allergy Rhinol. 2014;4(5):361–370.
   PubMed Web of Science ®Google Scholar
• Rogers GA, Den Beste K, Parkos CA, et al. Epithelial tight junction alterations in nasal polyposis. Int Forum Allergy Rhinol. 2011;1(1):50–54.
   PubMed Web of Science ®Google Scholar
• Soyka MB, Wawrzyniak P, Eiwegger T, et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol. 2012;130(5):1087–1096.e10.
   PubMed Web of Science ®Google Scholar
• Zuckerman JD, Lee WY, DelGaudio JM, et al. Pathophysiology of nasal polyposis: the role of desmosomal junctions. Am J Rhinol. 2008;22(6):589–597.
   PubMedGoogle Scholar
• Lane AP, Truong-Tran QA, Myers A, et al. Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol. 2006;20(1):117–123.
   PubMedGoogle Scholar
• Workman AD, Palmer JN, Adappa ND, et al. The role of bitter and sweet taste receptors in upper airway immunity. Curr Allergy Asthma Rep. 2015;15(12):72.
   PubMed Web of Science ®Google Scholar
• Stevens WW, Ocampo CJ, Berdnikovs S, et al. Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease. Am J Respir Crit Care Med. 2015;192(6):682–694.
   PubMed Web of Science ®Google Scholar
• Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137:1449–1456.e4.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zeng M, Liu Z. Th17 response and its regulation in inflammatory upper airway diseases. Clin Exp Allergy. 2015;45(3):602–612.
   PubMed Web of Science ®Google Scholar
• Mahdavinia M, Suh LA, Carter RG, et al. Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia. J Allergy Clin Immunol. 2015;135(2):576–579.
   PubMed Web of Science ®Google Scholar
• Kielgast F, Schmidt H, Braubach P, et al. Glucocorticoids regulate tight junction permeability of lung epithelia by modulating claudin 8. Am J Respir Cell Mol Biol. 2015;54(5):707–717.
   Web of Science ®Google Scholar
• Sekiyama A, Gon Y, Terakado M, et al. Glucocorticoids enhance airway epithelial barrier integrity. Int Immunopharmacol. 2012;12(2):350–357.
   PubMed Web of Science ®Google Scholar
• Schleimer RP. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc. 2004;1(3):222–230.
   PubMedGoogle Scholar
• Halwani R, Al-Muhsen S, Hamid Q. T helper 17 cells in airway diseases: from laboratory bench to bedside. Chest. 2013;143(2):494–501.
   PubMed Web of Science ®Google Scholar
• Belvisi MG. Regulation of inflammatory cell function by corticosteroids. Proc Am Thorac Soc. 2004;1(3):207–214.
   PubMedGoogle Scholar
• Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol. 2012;129(6):1522–1528 e5.
   PubMed Web of Science ®Google Scholar
• Zhou B, He G, Liang J, et al. Mometasone furoate nasal spray in the treatment of nasal polyposis in Chinese patients: a double-blind, randomized, placebo-controlled trial. Int Forum Allergy Rhinol. 2016;6(1):88–94.
   PubMed Web of Science ®Google Scholar
• Snidvongs K, Kalish L, Sacks R, et al. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev. 2011;(8):Cd009274.
   Google Scholar
• Chong LY, Head K, Hopkins C, et al. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:Cd011996.
   PubMedGoogle Scholar
• Kalish L, Snidvongs K, Sivasubramaniam R, et al. Topical steroids for nasal polyps. Cochrane Database Syst Rev. 2012;12:Cd006549.
   PubMedGoogle Scholar
• Fandino M, Macdonald KI, Lee J, et al. The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Am J Rhinol Allergy. 2013;27(5):e146–e157.
   PubMed Web of Science ®Google Scholar
• Head K, Chong LY, Hopkins C, et al. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:Cd011991.
   PubMedGoogle Scholar
• Head K, Chong LY, Hopkins C, et al. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:Cd011992.
   PubMed Web of Science ®Google Scholar
• Alobid I, Benitez P, Pujols L, et al. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinology. 2006;44(1):8–13.
   PubMed Web of Science ®Google Scholar
• Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118(1):128–133.
   PubMed Web of Science ®Google Scholar
• Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Clinical efficacy of a short course of systemic steroids in nasal polyposis. Rhinology. 2011;49(5):525–532.
   PubMed Web of Science ®Google Scholar
• Vaidyanathan S, Barnes M, Williamson P, et al. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med. 2011;154(5):293–302.
   PubMed Web of Science ®Google Scholar
• Leung RM, Dinnie K, Smith TL. When do the risks of repeated courses of corticosteroids exceed the risks of surgery? Int Forum Allergy Rhinol. 2014;4(11):871–876.
   PubMed Web of Science ®Google Scholar
• Cingi C, Muluk NB, Ipci K, et al. Antileukotrienes in upper airway inflammatory diseases. Curr Allergy Asthma Rep. 2015;15(11):64.
   PubMed Web of Science ®Google Scholar
• Chao SS, Graham SM, Brown CL, et al. Cysteinyl leukotriene 1 receptor expression in nasal polyps. Ann Otol Rhinol Laryngol. 2006;115(5):394–397.
   PubMed Web of Science ®Google Scholar
• Schaper C, Noga O, Koch B, et al. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis. J Investig Allergol Clin Immunol. 2011;21(1):51–58.
   PubMed Web of Science ®Google Scholar
• Pauli C, Fintelmann R, Klemens C, et al. [Polyposis nasi – improvement in quality of life by the influence of leukotrien receptor antagonists]. Laryngorhinootologie. 2007;86(4):282–286. German.
   PubMed Web of Science ®Google Scholar
• Vuralkan E, Saka C, Akin I, et al. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps. Ther Adv Respir Dis. 2012;6(1):5–10.
   PubMed Web of Science ®Google Scholar
• Mostafa BE, Abdel Hay H, Mohammed HE, et al. Role of leukotriene inhibitors in the postoperative management of nasal polyps. ORL J Otorhinolaryngol Relat Spec. 2005;67(3):148–153.
   PubMed Web of Science ®Google Scholar
• Smith TL, Sautter NB. Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis? Laryngoscope. 2014;124(8):1735–1736.
   PubMed Web of Science ®Google Scholar
• Stewart RA, Ram B, Hamilton G, et al. Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. Otolaryngol Head Neck Surg. 2008;139(5):682–687.
   PubMed Web of Science ®Google Scholar
• Antunes MB, Gudis DA, Cohen NA. Epithelium, cilia, and mucus: their importance in chronic rhinosinusitis. Immunol Allergy Clin North Am. 2009;29(4):631–643.
   PubMed Web of Science ®Google Scholar
• Wang X, Moylan B, Leopold DA, et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA. 2000;284(14):1814–1819.
   PubMed Web of Science ®Google Scholar
• Purkey MT, Li J, Mentch F, et al. Genetic variation in genes encoding airway epithelial potassium channels is associated with chronic rhinosinusitis in a pediatric population. PLoS One. 2014;9(3):e89329.
   PubMed Web of Science ®Google Scholar
• Ferguson JL, McCaffrey TV, Kern EB, et al. The effects of sinus bacteria on human ciliated nasal epithelium in vitro. Otolaryngol Head Neck Surg. 1988;98(4):299–304.
   PubMed Web of Science ®Google Scholar
• Chong LY, Head K, Hopkins C, et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:Cd011995.
   PubMedGoogle Scholar
• Achilles N, Mosges R. Nasal saline irrigations for the symptoms of acute and chronic rhinosinusitis. Curr Allergy Asthma Rep. 2013;13(2):229–235.
   PubMed Web of Science ®Google Scholar
• Cimmino M, Nardone M, Cavaliere M, et al. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch Otolaryngol Head Neck Surg. 2005;131(12):1097–1101.
   PubMedGoogle Scholar
• Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities. Allergy. 2015;70(5):533–539.
   PubMed Web of Science ®Google Scholar
• Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope. 2003;113(7):1199–1205.
   PubMed Web of Science ®Google Scholar
• Hur K, Liang J, Lin SY. The role of secondhand smoke in sinusitis: a systematic review. Int Forum Allergy Rhinol. 2014;4(1):22–28.
   PubMed Web of Science ®Google Scholar
• Reh DD, Higgins TS, Smith TL. Impact of tobacco smoke on chronic rhinosinusitis: a review of the literature. Int Forum Allergy Rhinol. 2012;2(5):362–369.
   PubMed Web of Science ®Google Scholar
• Goldstein-Daruech N, Cope EK, Zhao KQ, et al. Tobacco smoke mediated induction of sinonasal microbial biofilms. PLoS One. 2011;6(1):e15700.
   PubMed Web of Science ®Google Scholar
• Sundaresan, A.S., et al. Occupational and environmental risk factors for chronic rhinosinusitis: a systematic review. Int Forum Allergy Rhinol. 2015;5(11):996–1003.
   PubMed Web of Science ®Google Scholar
• Wilson KF, McMains KC, Orlandi RR. The association between allergy and chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2014;4(2):93–103.
   PubMed Web of Science ®Google Scholar
• Baroody FM, Mucha SM, Detineo M, et al. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008;121(5):1126–1132.e7.
   PubMed Web of Science ®Google Scholar
• Naclerio RM, deTineo ML, Baroody FM. Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study. Arch Otolaryngol Head Neck Surg. 1997;123(2):193–196.
   PubMedGoogle Scholar
• Bonfils P, Avan P, Malinvaud D. Influence of allergy on the symptoms and treatment of nasal polyposis. Acta Otolaryngol. 2006;126(8):839–844.
   PubMed Web of Science ®Google Scholar
• Pearlman AN, Chandra RK, Chang D, et al. Relationships between severity of chronic rhinosinusitis and nasal polyposis, asthma, and atopy. Am J Rhinol Allergy. 2009;23(2):145–148.
   PubMed Web of Science ®Google Scholar
• Keith PK, Conway M, Evans S, et al. Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol. 1994;93(3):567–574.
   PubMed Web of Science ®Google Scholar
• Erbek SS, Erbek S, Topal O, et al. The role of allergy in the severity of nasal polyposis. Am J Rhinol. 2007;21(6):686–690.
   PubMedGoogle Scholar
• Pant H, Ferguson BJ, Macardle PJ. The role of allergy in rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2009;17(3):232–238.
   PubMed Web of Science ®Google Scholar
• Chin D, Harvey RJ. Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment. Curr Opin Otolaryngol Head Neck Surg. 2013;21(1):23–30.
   PubMed Web of Science ®Google Scholar
• Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope. 2004;114(5):923–930.
   PubMed Web of Science ®Google Scholar
• Alobid I, Benitez P, Bernal-Sprekelsen M, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy. 2005;60(4):452–458.
   PubMed Web of Science ®Google Scholar
• Georgalas C, Cornet M, Adriaensen G, et al. Evidence-based surgery for chronic rhinosinusitis with and without nasal polyps. Curr Allergy Asthma Rep. 2014;14(4):427.
   PubMed Web of Science ®Google Scholar
• Dautremont JF, Rudmik L. When are we operating for chronic rhinosinusitis? A systematic review of maximal medical therapy protocols prior to endoscopic sinus surgery. Int Forum Allergy Rhinol. 2015;5(12):1095–1103.
   PubMed Web of Science ®Google Scholar
• Marple BF, Stankiewicz JA, Baroody FM, et al. Diagnosis and management of chronic rhinosinusitis in adults. Postgrad Med. 2009;121(6):121–139.
   PubMed Web of Science ®Google Scholar
• Smith TL, Kern R, Palmer JN, et al. Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study with 1-year follow-up. Int Forum Allergy Rhinol. 2013;3(1):4–9.
   PubMed Web of Science ®Google Scholar
• Smith KA, Smith TL, Mace JC, et al. Endoscopic sinus surgery compared to continued medical therapy for patients with refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(10):823–827.
   PubMed Web of Science ®Google Scholar
• Hopkins C, Rimmer J, Lund VJ. Does time to endoscopic sinus surgery impact outcomes in chronic rhinosinusitis? Prospective findings from the national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Rhinology. 2015;53(1):10–17.
   PubMed Web of Science ®Google Scholar
• Benninger MS, Sindwani R, Holy CE, et al. Impact of medically recalcitrant chronic rhinosinusitis on incidence of asthma. Int Forum Allergy Rhinol. 2016;6(2):124–129.
   PubMed Web of Science ®Google Scholar
• Orlandi RR, Kingdom TT, Hwang PH. international consensus statement on allergy and rhinology: rhinosinusitis executive summary. Int Forum Allergy Rhinol. 2016;6(Suppl 1):S3–s21.
   PubMed Web of Science ®Google Scholar
• DeConde AS, Suh JD, Mace JC, et al. Outcomes of complete vs targeted approaches to endoscopic sinus surgery. Int Forum Allergy Rhinol. 2015;5(8):691–700.
   PubMed Web of Science ®Google Scholar
• Chandra RK, Kern RC, Cutler JL, et al. REMODEL larger cohort with long-term outcomes and meta-analysis of standalone balloon dilation studies. Laryngoscope. 2016;126(1):44–50.
   PubMed Web of Science ®Google Scholar
• Hopkins C, Slack R, Lund V, et al. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope. 2009;119(12):2459–2465.
   PubMed Web of Science ®Google Scholar
• Van Zele T, Holtappels G, Gevaert P, et al. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2014;28(3):192–198.
   PubMed Web of Science ®Google Scholar
• Kosugi EM, Moussalem GF, Simoes JC, et al. Topical therapy with high-volume budesonide nasal irrigations in difficult-to-treat chronic rhinosinusitis. Braz J Otorhinolaryngol. 2016;82(2):191–197.
   PubMed Web of Science ®Google Scholar
• Wang C, Lou H, Wang X, et al. Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2015;135(4):922–929.e6.
   PubMed Web of Science ®Google Scholar
• Marple BF, Smith TL, Han JK, et al. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg. 2012;146(6):1004–1011.
   PubMed Web of Science ®Google Scholar
• Murr AH, Smith TL, Hwang PH, et al. Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int Forum Allergy Rhinol. 2011;1(1):23–32.
   PubMed Web of Science ®Google Scholar
• Rudmik L, Smith TL. Economic evaluation of a steroid-eluting sinus implant following endoscopic sinus surgery for chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2014;151(2):359–366.
   PubMed Web of Science ®Google Scholar
• Han JK, Forwith KD, Smith TL, et al. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinol. 2014;4(11):861–870.
   PubMed Web of Science ®Google Scholar
• Forwith KD, Han JK, Stolovitzky JP, et al. RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study. Int Forum Allergy Rhinol. 2016;6:573–581.
   PubMed Web of Science ®Google Scholar
• Normansell R, Walker S, Milan SJ, et al. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;1:Cd003559.
   PubMed Web of Science ®Google Scholar
• Pauwels B, Jonstam K, Bachert C. Emerging biologics for the treatment of chronic rhinosinusitis. Expert Rev Clin Immunol. 2015;11(3):349–361.
   PubMed Web of Science ®Google Scholar
• Lam K, Kern RC, Luong A. Is there a future for biologics in the management of chronic rhinosinusitis? Int Forum Allergy Rhinol. 2016:8. doi:10.1002/alr.21780.
   Web of Science ®Google Scholar
• Powell C, Milan SJ, Dwan K, et al. Mepolizumab versus placebo for asthma. Cochrane Database Syst Rev. 2015;7:Cd010834.
   PubMed Web of Science ®Google Scholar
• Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368(26):2455–2466.
   PubMed Web of Science ®Google Scholar
• Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469–479.
   PubMed Web of Science ®Google Scholar
• Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989–995.e1–8.
   Web of Science ®Google Scholar
• Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006;118(5):1133–1141.
   PubMed Web of Science ®Google Scholar
• Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131(1):110–6.e1.
   PubMed Web of Science ®Google Scholar
• Rudmik L, Soler ZM, Hopkins C, et al. Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study. Int Forum Allergy Rhinol. 2016;6:557–567.
   PubMed Web of Science ®Google Scholar